Sharp Therapeutics Corp. (SHRX : TSX-V)
Common Stock
$0.91
CAD
+0.00 (%)
Last updated: 2026-07-03
Get SHRX alerts:
SHRX
Sharp Therapeutics Corp.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-46.47%
Key Statistics
Market Cap
$27.37M
52W High
$5.00
52W Low
$0.25
P/E Ratio
-
50 Day MA
$0.92
200 Day MA
$1.91
Beta
-0.65
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/3/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 0 |
| 7/2/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 0 |
| 6/30/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 1,300 |
| 6/29/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/26/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/25/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/24/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/23/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/22/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/19/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SHRX's historical volatility
30-Day Vol
215.8%
Annualized
90-Day Vol
125.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.86 | C$0.41 – C$1.81 |
| 60 trading days | C$0.81 | C$0.28 – C$2.32 |
| 90 trading days | C$0.76 | C$0.21 – C$2.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sharp Therapeutics Corp.
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a custom-built, cloud-distributed analytics platform that captures data for AlloChem compounds in CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-5.53M
- Profit Margin
- 0.00%
- ROE (TTM)
- -3762.21%
- EPS (Diluted)
- -0.24
- Book Value
- -0.10
🔄 Recent Splits
1-for-10
Jan 27, 2025
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SHRX
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AAAJ-P | AAJ Capital 3 Corp. | $0.03 | +0.00% |
| AAA-P | First Tidal Acquisition Corp. | $0.06 | +0.00% |
| ABA | Abasca Resources Inc. | $0.09 | +0.00% |
| ABC | Absolutely Critical Resources Corp. | $0.01 | +0.00% |
| AB-H | Asbestos Corporation Limited | $0.90 | +0.00% |
| ABZ | Asiabasemetals Inc | $0.09 | +0.00% |
| ACAP-P | Atlas One Capital Corporation | $0.02 | +0.00% |
| ADAD-P | Adagio 2 Capital Inc. | $0.15 | +0.00% |
SHRX.V news timeline
1 article covering SHRX.V, most recent first
Latest